Abstract:Naïve CD4+ Th (T helper cells) can differentiate/be polarized in to 9 terminally differentiated Th cell subsets depending on the cytokine repertoire and anatomical location. CD4+ FOXP3+ (forkhead box P3) regulatory T cells (Treg) are one of the Th subsets. Treg are well known to suppress immuno‐pathological reactions in host immune system against antigens and dangers. Recently we proposed a novel concept, which suggested that pathological conditions re‐shape physiological Treg into pathological Treg that have weakened immuno‐suppressive functions and show increased plasticity. This was substantiated by several reports by demonstrating that there are endogenous mechanisms available to suppress Treg under various pathologies. Furthermore, Th1 like–Treg and Th17 like–Treg have also been reported. However, a comprehensive analysis was not conducted to identify whether Treg can convert into other immune cell types such as APCs (antigen presenting cells) when given the right condition. To test this hypothesis, we conducted an extensive experimental datamining approach. In our study, we analyzed the tissue expression patterns of as many as 61 Th subset regulators in physiological and pathological conditions. Our analysis revealed the following findings. 1) All the Th subset regulators are differentially expressed in various human tissues including heart and vascular tissues at physiological conditions. 2) Chronic metabolic diseases and autoimmune diseases increase multiple Th subset regulators but decrease Treg regulators. Familial hypercholesterolemia and lupus do not increase Th1 regulators. 3) Severe trauma increases Th2, Th9, Tfh, and Th17 subset regulators but decreases Th1 and Treg regulators in blood. In contrast, burn injury decreases all Th subset regulators except Th22 regulators. 4) Vascular cells are functional as innate immune cells, express numerous Th subsets‐promoting cytokines and induce Th regulator expression except the regulators for Treg. 5) Gata3 and Hdac6 promote, but Bcl6 inhibits, Th subset regulator expression in Treg, and regulate Treg plasticity and heterogeneity. 6) Gata3 and Bcl6 inhibit the expression of MHC class II, and T cell co‐signaling receptors in Treg; and consequently mutations of Gata3 and Bcl6 “trans‐differentiate” Treg into APC‐like Treg. Based on our findings, we conclude that increased plasticity of naïve T‐reg under pathological conditions with decreased expression of Gata3 and Bcl6 can upregulate MHC class II molecules and T cell co‐stimulation receptors expression that subsequently convert them to APC like‐Treg. Furthermore, our data suggested that Th subset may have various non‐immune activities as well. Our findings provide novel insights into Th subsets and Treg, which may lead to future development of novel therapeutics for the treatment of inflammation, cancers, transplantation, autoimmune diseases and tissue regeneration.Support or Funding InformationRO1‐HL132399‐01A1This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells

From Suppressor T cells to Regulatory T cells: How the Journey That Began with the Discovery of the Toxic Effects of TCDD Led to Better Understanding of the Role of AhR in Immunoregulation

High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells

Tcdd-Induced Activation Of Aryl Hydrocarbon Receptor Inhibits Th17 Polarization And Regulates Non-Eosinophilic Airway Inflammation In Asthma

Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs

AhR activation promotes Treg cell generation by enhancing Lkb1‐mediated fatty acid oxidation via the Skp2/K63‐ubiquitination pathway

Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses

TGF-β-induced CD4+ Regulatory T Cells but Not Ntregs Ameliorate Autoimmune Arthritis by Shifting the Balance Between Tregs and Th17 Cells in Vivo (179.14)

Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells

PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis

Retinoic Acid, IL-2 and TGF-β can Rapidly Induce Naïve Human CD4+ Cells to Become CD25+Foxp3+ Regulatory Cells with Protective Activity in vivo

Increased Plasticity of FOXP3+ Treg under Pathological Conditions Convert Treg into Either Novel Treg or Th1‐Treg

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway

All-Trans Retinoic Acid Promotes Tgf-Beta-Induced Tregs Via Histone Modification But Not Dna Demethylation On Foxp3 Gene Locus

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells

Regulatory T Cells Control Epitope Spreading in Autoimmune Arthritis Independent of Cytotoxic T‐lymphocyte Antigen‐4

GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.

Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells

Human CD39 hi regulatory T cells present stronger stability and function under inflammatory conditions

Differential Roles of TNFα-TNFR1 and TNFα-TNFR2 in the Differentiation and Function of CD4+Foxp3+ Induced Treg Cells in Vitro and in Vivo Periphery in Autoimmune Diseases